Long-Term Liabilities: The sum of all non-current liabilities.
Boundless Bio, Inc. (BOLD) had Long-Term Liabilities of $48.31M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.76M |
|
-- |
|
-- |
|
$17.34M |
|
$-17.34M |
|
$1.58M |
|
$-15.76M |
|
$-15.76M |
|
$-15.76M |
|
$-15.76M |
|
$-15.76M |
|
$-15.76M |
|
$-17.34M |
|
$-17.02M |
|
22.30M |
|
22.30M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$140.36M |
|
$4.08M |
|
$50.88M |
|
$191.24M |
|
$6.34M |
|
$48.31M |
|
|
Long-Term Liabilities |
$48.31M |
$54.65M |
|
$136.59M |
|
$136.59M |
|
$136.59M |
|
22.30M |
|
| Cash Flow Statement Financials | |
$-14.53M |
|
$3.06M |
|
-- |
|
$27.15M |
|
$15.68M |
|
$-11.47M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.15 |
|
-- |
|
-- |
|
0.26 |
|
0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.54% |
|
-11.54% |
|
-8.24% |
|
-8.52% |
|
$6.13 |
|
$-0.65 |
|
$-0.65 |
|